Unlicensed weight-loss drugs are being handed out as prizes in online giveaways, with powerful medicines unlicensed in the UK serving as the main attraction. The practice is a stark reminder of the dangers of unchecked digital marketing techniques and their application to pharmaceuticals.
On WhatsApp groups and Telegram channels, promoters are running "giveaway" competitions where participants can win injections of substances such as retatrutide β an experimental weight-loss drug that has not yet been approved for use anywhere in the world. These giveaways often come with a time-sensitive twist, with entrants being given only 24 hours to claim their prize.
Experts describe this practice as "extremely dangerous", warning that these digital marketing techniques are being applied to pharmaceuticals without proper regulation or oversight. The substances being promoted are tightly regulated medicines rather than harmless supplements, and advertising or distributing prescription-only or unlicensed medicines through social media competitions is a clear breach of medicines regulations.
The giveaways often take the form of coded messages, where users may be directed to join online coaching platforms under the guise of fitness programs. In reality, these platforms serve as frontmen for the sale of unlicensed weight-loss drugs. For example, a "fitness coach" named Rita might be used as shorthand for retatrutide.
The use of digital marketing techniques to promote powerful injectable drugs poses significant safety risks, as these substances are not subject to safety checks, quality controls or medical oversight. The fact that some promoters claim their services are "100% free to enter" and require only a minimal amount of effort from participants is also concerning.
Regulators are stepping in to crack down on this practice, with Meta stating that the sale of illegal medication is explicitly forbidden by its terms of service. Telegram has also taken action, routinely removing content related to the sale of unlicensed medicines whenever discovered. However, it remains to be seen whether these efforts will be enough to curb the spread of these giveaways.
As one expert noted, "Giveaways, countdown timers and raffles are classic pressure tactics designed to override caution... This not only trivialises the use of unlicensed medicines but actively discourages people from stopping to ask whether what's being offered is legal or appropriate." The practice poses a significant threat to public health, and it is essential that regulatory bodies take swift action to address this issue.
On WhatsApp groups and Telegram channels, promoters are running "giveaway" competitions where participants can win injections of substances such as retatrutide β an experimental weight-loss drug that has not yet been approved for use anywhere in the world. These giveaways often come with a time-sensitive twist, with entrants being given only 24 hours to claim their prize.
Experts describe this practice as "extremely dangerous", warning that these digital marketing techniques are being applied to pharmaceuticals without proper regulation or oversight. The substances being promoted are tightly regulated medicines rather than harmless supplements, and advertising or distributing prescription-only or unlicensed medicines through social media competitions is a clear breach of medicines regulations.
The giveaways often take the form of coded messages, where users may be directed to join online coaching platforms under the guise of fitness programs. In reality, these platforms serve as frontmen for the sale of unlicensed weight-loss drugs. For example, a "fitness coach" named Rita might be used as shorthand for retatrutide.
The use of digital marketing techniques to promote powerful injectable drugs poses significant safety risks, as these substances are not subject to safety checks, quality controls or medical oversight. The fact that some promoters claim their services are "100% free to enter" and require only a minimal amount of effort from participants is also concerning.
Regulators are stepping in to crack down on this practice, with Meta stating that the sale of illegal medication is explicitly forbidden by its terms of service. Telegram has also taken action, routinely removing content related to the sale of unlicensed medicines whenever discovered. However, it remains to be seen whether these efforts will be enough to curb the spread of these giveaways.
As one expert noted, "Giveaways, countdown timers and raffles are classic pressure tactics designed to override caution... This not only trivialises the use of unlicensed medicines but actively discourages people from stopping to ask whether what's being offered is legal or appropriate." The practice poses a significant threat to public health, and it is essential that regulatory bodies take swift action to address this issue.